Home

Внимание театър естествен astra zeneca nature същност Разопаковане орално

AstraZeneca-Oxford Coronavirus Vaccine Trials Paused After Unexpected  Illness In Volunteer
AstraZeneca-Oxford Coronavirus Vaccine Trials Paused After Unexpected Illness In Volunteer

Halting the Oxford vaccine trial doesn't mean it's not safe – it shows  they're following the right process
Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process

AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report  - world news - Hindustan Times
AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report - world news - Hindustan Times

Israel - AstraZeneca
Israel - AstraZeneca

AstraZeneca Covid-19 vaccine study is put on hold
AstraZeneca Covid-19 vaccine study is put on hold

AstraZeneca Covid-19 vaccine trial volunteer dies: Brazil
AstraZeneca Covid-19 vaccine trial volunteer dies: Brazil

COVID-19: Difficult trade-offs in AstraZeneca vaccine development |  Science| In-depth reporting on science and technology | DW | 28.10.2020
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020

Egypt - AstraZeneca
Egypt - AstraZeneca

PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A  five-dimensional framework
PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework

AstraZeneca México - Videos | Facebook
AstraZeneca México - Videos | Facebook

PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A  five-dimensional framework
PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework

The COVID vaccine challenges that lie ahead
The COVID vaccine challenges that lie ahead

Oxford Covid-19 vaccine trial put on hold after participant falls ill
Oxford Covid-19 vaccine trial put on hold after participant falls ill

EUR068: Enforcement (No. 2006/857/EC, Case COMP/A.37.507/F3 — AstraZeneca),  Decision, 2005
EUR068: Enforcement (No. 2006/857/EC, Case COMP/A.37.507/F3 — AstraZeneca), Decision, 2005

Why AstraZeneca and others racing to make a COVID-19 vaccine should be more  open about the process
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process

Oxford and AstraZeneca to resume Covid vaccine trial, Health News, ET  HealthWorld
Oxford and AstraZeneca to resume Covid vaccine trial, Health News, ET HealthWorld

A leading coronavirus vaccine trial is on hold: scientists react
A leading coronavirus vaccine trial is on hold: scientists react

APO Group - Africa Newsroom / Press release | AstraZeneca to partner with  UNICEF to help prevent non-communicable diseases among five million young  people worldwide
APO Group - Africa Newsroom / Press release | AstraZeneca to partner with UNICEF to help prevent non-communicable diseases among five million young people worldwide

Coronavirus vaccine: Europe's Inclusive Vaccines Alliance strikes giant  agreement with AstraZeneca | Euronews
Coronavirus vaccine: Europe's Inclusive Vaccines Alliance strikes giant agreement with AstraZeneca | Euronews

Investments in health systems
Investments in health systems

COVID-19 clinical MDT experience sharing webcast
COVID-19 clinical MDT experience sharing webcast

AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it |  FiercePharma
AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it | FiercePharma

AstraZeneca deal to supply EU with 300 million COVID-19 vaccine doses - CGTN
AstraZeneca deal to supply EU with 300 million COVID-19 vaccine doses - CGTN

Greening Australia to deliver one of Australia's largest-ever restoration  projects - Greening Australia - Greening Australia
Greening Australia to deliver one of Australia's largest-ever restoration projects - Greening Australia - Greening Australia

News in brief | Nature Reviews Drug Discovery
News in brief | Nature Reviews Drug Discovery

AstraZeneca COVID-19 vaccine shows average efficiency of 70% - CGTN
AstraZeneca COVID-19 vaccine shows average efficiency of 70% - CGTN